辛伐他汀与米贝拉地尔相互作用导致的横纹肌溶解症。 - Suppr

Suppr

超能文献

Rhabdomyolysis due to interaction of simvastatin with mibefradil.

作者信息

Schmassmann-Suhijar D, Bullingham R, Gasser R, Schmutz J, Haefeli W E

出版信息

Lancet. 1998 Jun 27;351(9120):1929-30. doi: 10.1016/S0140-6736(05)78613-X.

DOI:10.1016/S0140-6736(05)78613-X

PMID:9654265

Abstract

摘要

相似文献

Rhabdomyolysis due to interaction of simvastatin with mibefradil.

Lancet. 1998 Jun 27;351(9120):1929-30. doi: 10.1016/S0140-6736(05)78613-X.

Case report: rhabdomyolysis induced by mibefradil in a patient treated with cyclosporine and simvastatin.

J Clin Pharmacol. 1999 Mar;39(3):310-2.

Mibefradil withdrawn from the market.

Ann Pharmacother. 1998 Jul-Aug;32(7-8):841. doi: 10.1345/aph.17356.

[Induction of bradycardia by mibefradil in antihypertensive combination therapy].

Dtsch Med Wochenschr. 1998 Apr 24;123(17):547.

Mibefradil (posicor).

Compr Ther. 1997 Nov;23(11):761-3.

Mibefradil: a new class of calcium-channel antagonists.

Ann Pharmacother. 1998 Jun;32(6):659-71. doi: 10.1345/aph.17323.

Good news for experimental concept but bad news for clinically effective therapy.

Circulation. 1999 Jan 19;99(2):198-200. doi: 10.1161/01.cir.99.2.198.

[Introducing mibefradil--a new T-calcium channel blocker].

Internist (Berl). 1997 Dec;38(12 Suppl Mibefradil):1-4.

[Mibefradil: a new class calcium inhibitor].

Internist (Berl). 1996 Oct;37(10 Suppl Mibefradil):1-8.

The withdrawal of mibefradil (Posicor).

Adverse Drug React Toxicol Rev. 1998 Jun-Sep;17(2-3):59-60.

引用本文的文献

Influence of statin intervention on peripheral neuropathy in patients treated with anticancer drugs identified from the insurer database.

J Pharm Health Care Sci. 2025 Apr 7;11(1):27. doi: 10.1186/s40780-025-00428-3.

Anti-Anginal Efficacy of Zibotentan in the Coronary Slow-Flow Phenomenon.

J Clin Med. 2024 Feb 27;13(5):1337. doi: 10.3390/jcm13051337.

Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information.

NPJ Digit Med. 2022 Jul 11;5(1):88. doi: 10.1038/s41746-022-00639-0.

Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore.

Oncotarget. 2021 Apr 27;12(9):891-906. doi: 10.18632/oncotarget.27933.

Characteristic and Mechanism of Drug-Herb Interaction Between Acetylsalicylic Acid and Danhong Injection Mediated by Organic Anion Transporters.

Front Pharmacol. 2020 Oct 2;11:577012. doi: 10.3389/fphar.2020.577012. eCollection 2020.

Informatics confronts drug-drug interactions.

Trends Pharmacol Sci. 2013 Mar;34(3):178-84. doi: 10.1016/j.tips.2013.01.006. Epub 2013 Feb 13.

ADME of biologics-what have we learned from small molecules?

AAPS J. 2012 Sep;14(3):410-9. doi: 10.1208/s12248-012-9353-6. Epub 2012 Apr 7.

Objective assessment of nonadherence and unknown co-medication in hospitalized patients.

Eur J Clin Pharmacol. 2012 Aug;68(8):1191-9. doi: 10.1007/s00228-012-1229-2. Epub 2012 Feb 22.

Deleterious effects of reactive metabolites.

Oxid Med Cell Longev. 2010 Jul-Aug;3(4):238-53. doi: 10.4161/oxim.3.4.13246.

Transporters in drug development: advancing on the Critical Path.

Nat Rev Drug Discov. 2010 Mar;9(3):175-6. doi: 10.1038/nrd3124.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验